EDAP TMS SA
Business
EDAP TMS SA is a medical technology company developing, manufacturing, marketing, and selling non-invasive therapeutic ultrasound devices, primarily the Focal One Robotic HIFU system for prostate cancer treatment. The company's core offering includes capital equipment sales combined with recurring revenue from consumables and maintenance services on its installed base. EDAP operates through direct sales subsidiaries in the United States, Europe, Asia, and other international markets, with expanding clinical applications in benign prostatic hyperplasia and deep infiltrating endometriosis.
Summary from 10-K filed 2026-03-25
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 |
|---|---|---|---|
| Total revenues | 71 | 69 | |
| Total cost of sales | −41 | −41 | |
| Gross profit | 30 | 29 | |
| Research and development expenses | −10 | −8 | |
| Selling and marketing expenses | −27 | −27 | |
| General and administrative expenses | −18 | −15 | |
| Income (loss) from operations | −25 | −22 | |
| Financial (expense) income, net | −3 | 606,000 | |
| Foreign currency exchange gain (loss), net | −1 | 1 | |
| Loss before taxes | −29 | −20 | |
| Income tax expense | −438,000 | −313,000 | |
| Loss | −29 | −21 | |
| Basic loss per share | −0.78 | −0.55 | |
| Diluted loss per share | −0.78 | −0.55 | |
| Basic Weighted average shares outstanding (in shares) | 37 | 37 | |
| Diluted Weighted average shares outstanding (in shares) | 37 | 37 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 20 | 31 | — | |
| Current portion of net trade accounts and notes receivable | 21 | 19 | — | |
| Other receivables | 1 | 2 | — | |
| Inventories | 13 | 19 | — | |
| Other assets, current portion | 1 | 1 | — | |
| Total current assets | 57 | 73 | — | |
| Property and equipment, net | 10 | 8 | — | |
| Operating lease right-of-use assets | 3 | 3 | — | |
| Intangible assets, net | 2 | 1 | — | |
| Goodwill | 3 | 3 | — | |
| Deposits and other non-current assets | 2 | 2 | — | |
| Deferred tax assets | 1 | 865,000 | — | |
| Net Trade accounts and notes receivable, non-current | 546,000 | — | — | |
| Total assets | 79 | 89 | — | |
| Trade accounts and notes payable | 12 | 13 | — | |
| Deferred revenues, current portion | 7 | 7 | — | |
| Social security and other payroll withholdings taxes | 2 | 2 | — | |
| Employee absences compensation | 1 | 1 | — | |
| Income taxes payable | 193,000 | −8,000 | — | |
| Other accrued liabilities | 5 | 6 | — | |
| Short-term borrowings | 6 | 6 | — | |
| Current obligations under finance leases | 182,000 | 175,000 | — | |
| Current portion of operating lease obligations | 1 | 1 | — | |
| Current portion of long-term debt | 2 | 3 | — | |
| Total current liabilities | 37 | 39 | — | |
| Deferred revenues, non-current | 966,000 | 372,000 | — | |
| Obligations under finance leases | 355,000 | 364,000 | — | |
| Operating lease obligations, non-current | 2 | 2 | — | |
| Long-term debt, non-current | 16 | 2 | — | |
| Other long-term liabilities | 3 | 3 | — | |
| Total liabilities | 60 | 47 | — | |
| Common stock at 0.13, or $0.15 at closing rate par value; 37,751,519 shares authorized and issued and 37,481,986 shares outstanding at December 31, 2025 0.13 or $0.14 at closing rate par value 37,661,619 shares authorized and issued and 37,392,086 shares outstanding at December 31, 2024 | 6 | 6 | — | |
| Additional paid-in capital | 151 | 149 | — | |
| Accumulated deficit | −129 | −99 | — | |
| Cumulative other comprehensive loss | −8 | −12 | — | |
| Treasury stock, at cost 269,533 shares at December 31, 2025 and 269,533 shares at December 31, 2024 | −1 | −1 | — | |
| Total shareholders' equity | 19 | 42 | 63 | |
| Total liabilities and shareholders' equity | 79 | 89 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 |
|---|---|---|---|
| Net loss | −29 | −21 | |
| Depreciation and amortization | 3 | 3 | |
| Share based compensation | 3 | 4 | |
| Change in allowances for doubtful accounts & slow-moving inventories | 919,000 | 1 | |
| Change in Fair Value on EIB Warrants and Loan amortization | 3 | — | |
| Change in long-term provisions | −140,000 | 187,000 | |
| Net capital loss on disposals of assets | 529,000 | 558,000 | |
| Deferred tax expense (benefit) | −231,000 | −105,000 | |
| Operating cash flow before changes in working capital | −19 | −13 | |
| Decrease (Increase) in trade accounts and notes and other receivables | −567,000 | −150,000 | |
| Decrease (Increase) in inventories | 7 | −4 | |
| Decrease (Increase) in other assets | 72,000 | −620,000 | |
| (Decrease) Increase in trade accounts and notes payable | −3 | 1 | |
| (Decrease) Increase in accrued expenses, other current liabilities | −462,000 | 2 | |
| Net change in operating assets and liabilities | 3 | −2 | |
| Net cash generated by (used in) operating activities | −16 | −15 | |
| Additions to capitalized assets produced by the Company | −4 | −3 | |
| Acquisitions of property and equipment | −1 | −1 | |
| Acquisitions of intangible assets | −832,000 | −249,000 | |
| Decrease (Increase) of other financial assets | 0 | — | |
| Decrease (Increase) in deposits and guarantees | 43,000 | −21,000 | |
| Net cash generated by (used in) investing activities | −6 | −4 | |
| Proceeds from stock-option exercise | — | 125,000 | |
| Proceeds from long term borrowings, net of financing costs | 12 | 3 | |
| Repayment of long term borrowings | −3 | −2 | |
| Repayment of obligations under financing leases | −205,000 | −251,000 | |
| Increase (decrease) in bank overdrafts and short-term borrowings | −883,000 | 4 | |
| Net cash generated by (used in) financing activities | 9 | 5 | |
| Net effect of exchange rate changes on cash and cash equivalents | 3 | −3 | |
| Net increase (decrease) in cash and cash equivalents | −11 | −17 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is EDAP TMS SA's CIK number?
EDAP TMS SA's SEC CIK number is 0001041934 (1041934). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find EDAP TMS SA's SEC filings?
All of EDAP TMS SA's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did EDAP TMS SA last report earnings?
EDAP TMS SA (FOCL) most recently filed an earnings 8-K with the SEC on May 7, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001171843-26-003113). This is EDAP TMS SA's most recent earnings filing of record — not a forecast of its next earnings date.
What is EDAP TMS SA's most recent earnings 8-K?
EDAP TMS SA's latest earnings 8-K (Item 2.02) was filed May 7, 2026 under accession 0001171843-26-003113. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View EDAP TMS SA's latest earnings 8-K →
Look up any company's CIK number →